| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | acyltransferase activity | MYCBP2 RNF112 CUL9 SRCAP BIRC6 NAGS TGM5 UBA7 PIAS3 KAT8 TRIM38 SLC27A3 OGT RMND5A UBR4 KAT6A SPTLC1 TRIM39 MED1 PIAS1 RNFT2 NEURL4 | 1.31e-05 | 775 | 202 | 22 | GO:0016746 |
| Domain | LRR_6 | 2.62e-05 | 55 | 200 | 6 | PF13516 | |
| Domain | PPR_long | 1.14e-04 | 2 | 200 | 2 | IPR033443 | |
| Domain | PPR_long | 1.14e-04 | 2 | 200 | 2 | PF17177 | |
| Domain | CRAL_TRIO_N | 1.87e-04 | 11 | 200 | 3 | PF03765 | |
| Domain | CRAL-bd_toc_tran | 2.48e-04 | 12 | 200 | 3 | IPR001071 | |
| Domain | CRAL_TRIO_N | 2.48e-04 | 12 | 200 | 3 | SM01100 | |
| Domain | ARM-type_fold | USP9X CUL9 NCAPD3 MYBBP1A TNPO2 UBR4 RICTOR ZNFX1 FRYL VIRMA ARID2 HTT | 3.06e-04 | 339 | 200 | 12 | IPR016024 |
| Domain | FHA_DOMAIN | 3.20e-04 | 31 | 200 | 4 | PS50006 | |
| Domain | PPR_3 | 3.40e-04 | 3 | 200 | 2 | PF13812 | |
| Domain | - | CTTNBP2 ANKRD37 ANKMY1 TRANK1 BANK1 ANKK1 ANKRD26 ANKRD23 ANKRD44 TANC1 | 3.53e-04 | 248 | 200 | 10 | 1.25.40.20 |
| Domain | ANK_REPEAT | CTTNBP2 ANKRD37 ANKMY1 TRANK1 BANK1 ANKK1 ANKRD26 ANKRD23 ANKRD44 TANC1 | 4.13e-04 | 253 | 200 | 10 | PS50088 |
| Domain | Ankyrin_rpt-contain_dom | CTTNBP2 ANKRD37 ANKMY1 TRANK1 BANK1 ANKK1 ANKRD26 ANKRD23 ANKRD44 TANC1 | 4.26e-04 | 254 | 200 | 10 | IPR020683 |
| Domain | ANK_REP_REGION | CTTNBP2 ANKRD37 ANKMY1 TRANK1 BANK1 ANKK1 ANKRD26 ANKRD23 ANKRD44 TANC1 | 4.26e-04 | 254 | 200 | 10 | PS50297 |
| Domain | CRAL/TRIO_N_dom | 5.01e-04 | 15 | 200 | 3 | IPR011074 | |
| Domain | EMP24_GP25L | 5.01e-04 | 15 | 200 | 3 | PF01105 | |
| Domain | Ankyrin_rpt | CTTNBP2 ANKRD37 ANKMY1 TRANK1 BANK1 ANKK1 ANKRD26 ANKRD23 ANKRD44 TANC1 | 5.43e-04 | 262 | 200 | 10 | IPR002110 |
| Domain | - | 5.75e-04 | 36 | 200 | 4 | 2.60.200.20 | |
| Domain | FHA_dom | 5.75e-04 | 36 | 200 | 4 | IPR000253 | |
| Domain | PPR | 6.75e-04 | 4 | 200 | 2 | PF01535 | |
| Domain | PINIT | 6.75e-04 | 4 | 200 | 2 | PS51466 | |
| Domain | PINIT | 6.75e-04 | 4 | 200 | 2 | PF14324 | |
| Domain | PINIT | 6.75e-04 | 4 | 200 | 2 | IPR023321 | |
| Domain | ARM-like | 6.85e-04 | 270 | 200 | 10 | IPR011989 | |
| Domain | GOLD_dom | 1.03e-03 | 19 | 200 | 3 | IPR009038 | |
| Domain | GOLD | 1.03e-03 | 19 | 200 | 3 | PS50866 | |
| Domain | Anaphylatoxin_comp_syst | 1.12e-03 | 5 | 200 | 2 | IPR018081 | |
| Domain | HAT_MYST-type | 1.12e-03 | 5 | 200 | 2 | IPR002717 | |
| Domain | Anaphylatoxn_comp_syst_dom | 1.12e-03 | 5 | 200 | 2 | IPR001840 | |
| Domain | Autophagy-rel_C | 1.12e-03 | 5 | 200 | 2 | IPR015412 | |
| Domain | ATG_C | 1.12e-03 | 5 | 200 | 2 | PF09333 | |
| Domain | MOZ_SAS | 1.12e-03 | 5 | 200 | 2 | PF01853 | |
| Domain | GATase | 1.12e-03 | 5 | 200 | 2 | PF00117 | |
| Domain | MYST_HAT | 1.12e-03 | 5 | 200 | 2 | PS51726 | |
| Domain | CRAL_TRIO | 1.40e-03 | 21 | 200 | 3 | PF00650 | |
| Domain | ANK | CTTNBP2 ANKRD37 ANKMY1 TRANK1 ANKK1 ANKRD26 ANKRD23 ANKRD44 TANC1 | 1.58e-03 | 251 | 200 | 9 | SM00248 |
| Domain | DAPIN | 1.60e-03 | 22 | 200 | 3 | PS50824 | |
| Domain | PYRIN | 1.60e-03 | 22 | 200 | 3 | SM01289 | |
| Domain | PYRIN | 1.60e-03 | 22 | 200 | 3 | PF02758 | |
| Domain | DAPIN | 1.60e-03 | 22 | 200 | 3 | IPR004020 | |
| Domain | Kinesin_assoc | 1.66e-03 | 6 | 200 | 2 | PF16183 | |
| Domain | GATASE_TYPE_1 | 1.66e-03 | 6 | 200 | 2 | PS51273 | |
| Domain | Haem_d1 | 1.66e-03 | 6 | 200 | 2 | IPR011048 | |
| Domain | GATASE | 1.66e-03 | 6 | 200 | 2 | IPR017926 | |
| Domain | Kinesin_assoc | 1.66e-03 | 6 | 200 | 2 | IPR032405 | |
| Domain | NACHT | 1.83e-03 | 23 | 200 | 3 | PS50837 | |
| Domain | - | 1.83e-03 | 23 | 200 | 3 | 3.40.525.10 | |
| Domain | NACHT_NTPase | 1.83e-03 | 23 | 200 | 3 | IPR007111 | |
| Domain | Pentatricopeptide_repeat | 1.83e-03 | 23 | 200 | 3 | IPR002885 | |
| Domain | Ank_2 | 2.26e-03 | 215 | 200 | 8 | PF12796 | |
| Domain | SMAD_FHA_domain | 2.31e-03 | 52 | 200 | 4 | IPR008984 | |
| Domain | ANATO | 2.31e-03 | 7 | 200 | 2 | SM00104 | |
| Domain | APC_su10/DOC_dom | 2.31e-03 | 7 | 200 | 2 | IPR004939 | |
| Domain | zf-MIZ | 2.31e-03 | 7 | 200 | 2 | PF02891 | |
| Domain | ZF_SP_RING | 2.31e-03 | 7 | 200 | 2 | PS51044 | |
| Domain | DOC | 2.31e-03 | 7 | 200 | 2 | PS51284 | |
| Domain | ANAPHYLATOXIN_2 | 2.31e-03 | 7 | 200 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 2.31e-03 | 7 | 200 | 2 | PS01177 | |
| Domain | ANAPC10 | 2.31e-03 | 7 | 200 | 2 | PF03256 | |
| Domain | ANATO | 2.31e-03 | 7 | 200 | 2 | PF01821 | |
| Domain | APC10 | 2.31e-03 | 7 | 200 | 2 | SM01337 | |
| Domain | Anaphylatoxin/fibulin | 2.31e-03 | 7 | 200 | 2 | IPR000020 | |
| Domain | SEC14 | 2.34e-03 | 25 | 200 | 3 | SM00516 | |
| Pubmed | MYCBP2 USP11 USP9X GART CUL9 BIRC6 DST MDN1 WDR75 KIF14 DYNC1H1 MYBBP1A CAD COPA TUT7 UBR4 NSD1 BEND3 FRYL VIRMA LRPPRC | 3.53e-10 | 653 | 204 | 21 | 22586326 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MYCBP2 ANKRD37 SIPA1L3 CUL9 ATG2A SRCAP BIRC6 TBC1D9 VOPP1 DST MDN1 PREX1 DYNC1H1 PKN3 PHF12 UBR4 KAT6A NSD1 FRYL CCDC88C BRD2 NEK8 TANC1 TRIB1 HTT HR | 2.03e-09 | 1105 | 204 | 26 | 35748872 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | RNF112 NCAPD3 MYBBP1A CAD COPA TUT7 RICTOR ZNFX1 FRYL MED1 LRRC31 NEURL4 | 3.13e-09 | 202 | 204 | 12 | 33005030 |
| Pubmed | ZNF148 MYCBP2 USP9X SRCAP KIF14 DYNC1H1 MYBBP1A CAD OGT APBB1 NSD1 BEND3 MED1 MED15 ARID2 CTPS1 EPB41 HTT | 5.06e-09 | 549 | 204 | 18 | 38280479 | |
| Pubmed | ZNF148 USP11 USP9X CUL9 SRCAP DST AGO3 KAT8 DYNC1H1 MYBBP1A CAD OGT LHX4 COPA TNPO2 PHF12 POLH UBR4 BEND3 PIAS1 RLF MED15 CASP12 BRD2 ZFHX4 ARID2 RACGAP1 PAN3 TRIB1 | 6.19e-09 | 1429 | 204 | 29 | 35140242 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | SETX MYCBP2 SIPA1L3 KIF1B CDK14 PANK2 DST MDN1 CLK3 KIF14 CARMIL1 APBB1 ANKRD26 RICTOR FRYL VIRMA CCDC88C LRPPRC RACGAP1 TANC1 PAN3 EPB41 | 9.02e-09 | 861 | 204 | 22 | 36931259 |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | MYCBP2 USP11 USP9X KIF1B GART CDK14 CCN4 CDAN1 PANK2 CLK3 BCL10 PREX1 DYNC1H1 NRBP1 MYBBP1A OGT TNPO2 UBR4 SPTLC1 FRYL CCNH RASGRP1 LRPPRC RACGAP1 CTPS1 NEURL4 EPB41 | 1.04e-08 | 1284 | 204 | 27 | 17353931 |
| Pubmed | MYCBP2 USP11 USP9X SIPA1L3 KIF1B CUL9 CHUK GUF1 DGLUCY UBA7 DST PIAS3 ZNF624 PREX1 DYNC1H1 KLHL4 NRBP1 OGT COPA TNPO2 UBR4 APBB1 ZNFX1 PIAS1 BRD2 CADPS2 MITD1 | 1.06e-08 | 1285 | 204 | 27 | 35914814 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | SETX TOPAZ1 RNF112 BIRC6 FABP7 CCN4 DST MDN1 AGL VPS13A BANK1 DYNC1H1 CFAP47 CYP26B1 TNPO2 UBR4 CCDC39 ARHGEF33 CEP295 CTPS1 | 1.62e-08 | 736 | 204 | 20 | 29676528 |
| Pubmed | USP9X SERPINB5 MDN1 WDR75 VPS13A PREX1 KNL1 NCAPD3 PHF12 UBR4 APBB1 ZNFX1 MED1 PIAS1 VIRMA MED15 ARID2 CEP295 | 4.99e-08 | 638 | 204 | 18 | 31182584 | |
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | CTTNBP2 MYCBP2 SIPA1L3 CUL9 DST NCAPD3 RMND5A UBR4 LRPPRC ARID2 NEURL4 | 5.78e-08 | 212 | 204 | 11 | 33853758 |
| Pubmed | SETX SIPA1L3 GUF1 TRMT10C DST MDN1 WDR75 CLK3 KAT8 KIF14 PREX1 NCAPD3 CAD OGT PHF12 NSD1 RICTOR MED1 PIAS1 VIRMA MED15 CCNH BRD2 PTCD1 ARID2 TANC1 EIF2A EPB41 | 6.45e-08 | 1497 | 204 | 28 | 31527615 | |
| Pubmed | 1.99e-07 | 3 | 204 | 3 | 15033454 | ||
| Pubmed | ATP8B4 CTTNBP2 SIPA1L3 ZNF623 BIRC6 TBC1D9 AMIGO1 PREX1 PUS7 ANKRD26 RICTOR CCDC88C PTCD1 ARID2 NEURL4 | 2.62e-07 | 493 | 204 | 15 | 15368895 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | SETX ZNF148 SRCAP ZNF780A KAT8 OGT PHF12 POLH KAT6A NSD1 MED1 PIAS1 RLF BRD2 ARID2 RACGAP1 | 7.13e-07 | 608 | 204 | 16 | 36089195 |
| Pubmed | Cloning of novel human SEC14p-like proteins: ligand binding and functional properties. | 7.92e-07 | 4 | 204 | 3 | 12757856 | |
| Pubmed | ZNF148 MYCBP2 BIRC6 DST KIF14 KNL1 OGT PHF12 POLH UBR4 BEND3 RLF ZFHX4 | 1.32e-06 | 418 | 204 | 13 | 34709266 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SETX MYCBP2 USP11 GART SRCAP BIRC6 BLVRA GUF1 DST MDN1 WDR75 DYNC1H1 MYBBP1A CAD COPA TUT7 UBR4 RICTOR RLF LRPPRC RACGAP1 TANC1 CTPS1 EIF2A | 1.55e-06 | 1353 | 204 | 24 | 29467282 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | TOPAZ1 USP9X L2HGDH TGM5 TRANK1 MDN1 C4A C4B CARMIL1 SRCIN1 RNFT2 ARID2 CTPS1 HYDIN | 1.64e-06 | 497 | 204 | 14 | 36774506 |
| Pubmed | ZNF148 MYCBP2 USP11 DMXL1 GUF1 TRMT10C MDN1 WDR75 VPS13A HINT2 PUS7 NRBP1 MYBBP1A CAD UBR4 SPTLC1 APBB1 ANKRD26 RICTOR LRPPRC BRD2 PTCD1 TANC1 EIF2A NEURL4 | 2.39e-06 | 1487 | 204 | 25 | 33957083 | |
| Pubmed | CTTNBP2 USP9X SIPA1L3 KIF1B BIRC6 DST KIF14 ANKRD26 RICTOR FRYL ANKRD44 CCDC88C CEP295 | 2.68e-06 | 446 | 204 | 13 | 24255178 | |
| Pubmed | ZNF148 DCDC1 USP11 CUL9 SRCAP AGO3 SCML1 KNL1 WDR72 OGT PHF12 KAT6A SPTLC1 BEND3 RICTOR ARHGEF33 BRD2 ZFHX4 ARID2 CEP295 TANC1 | 2.94e-06 | 1116 | 204 | 21 | 31753913 | |
| Pubmed | SETX ZNF148 MDN1 PIAS3 DCLRE1A KNL1 NCAPD3 OGT PHF12 NSD1 BEND3 MED1 MED15 | 3.18e-06 | 453 | 204 | 13 | 29656893 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | SIPA1L3 KIF1B ATG2A AGO3 KIF14 DYNC1H1 PHF12 CARMIL1 TUT7 ANKRD26 CCDC88C MTAP CEP295 TANC1 PAN3 EIF2A NEURL4 EPB41 | 3.29e-06 | 853 | 204 | 18 | 28718761 |
| Pubmed | Variants in TF and HFE explain approximately 40% of genetic variation in serum-transferrin levels. | 3.30e-06 | 18 | 204 | 4 | 19084217 | |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | USP11 USP9X SIPA1L3 CDK14 CHUK CLK3 KAT8 SNU13 MYBBP1A MKNK2 MED1 MED15 CCNH ZNF33A CHEK2 NEURL4 | 3.98e-06 | 695 | 204 | 16 | 23602568 |
| Pubmed | CTTNBP2 MYCBP2 USP9X SIPA1L3 DST MDN1 AGO3 DYNC1H1 MYBBP1A CAD OGT UBR4 NSD1 ZNFX1 VIRMA CCDC88C LRPPRC RACGAP1 NEURL4 | 4.58e-06 | 963 | 204 | 19 | 28671696 | |
| Pubmed | SIPA1L3 EML6 SRCAP CHUK DST MDN1 WDR75 SCN4A VPS13A ANTXR1 SNU13 PREX1 ERICH6 MYBBP1A COPA UBR4 ANKRD26 BEND3 CCNH LRPPRC MTAP BRD2 CEP295 CADPS2 | 4.59e-06 | 1442 | 204 | 24 | 35575683 | |
| Pubmed | 5.88e-06 | 76 | 204 | 6 | 27542412 | ||
| Pubmed | 6.84e-06 | 7 | 204 | 3 | 19728335 | ||
| Pubmed | SETX L2HGDH DST ANTXR1 C4A C4B NCAPD3 OGT TUT7 RICTOR ZNFX1 PIAS1 RACGAP1 TANC1 HR | 7.81e-06 | 650 | 204 | 15 | 38777146 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MYCBP2 SIPA1L3 KIF1B L2HGDH ANKMY1 CDK14 LRFN2 ANTXR1 LUZP2 OGT CARMIL1 KAT6A FRYL SRCIN1 CLDN12 RLF ANKRD44 LRPPRC ZNF33A ZNF33B TANC1 PAN3 EPB41 HTT | 7.84e-06 | 1489 | 204 | 24 | 28611215 |
| Pubmed | SETX ZNF148 MYCBP2 KAT8 DYNC1H1 KNL1 NCAPD3 CAD OGT TNPO2 PHF12 BEND3 MED1 PIAS1 RLF MED15 ARID2 CTPS1 EIF2A MITD1 | 8.83e-06 | 1103 | 204 | 20 | 34189442 | |
| Pubmed | A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers. | 9.57e-06 | 125 | 204 | 7 | 21654808 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | SETX USP11 USP9X KIF1B CUL9 SRCAP KIF14 KNL1 CAD OGT ANKRD26 PIAS1 ARID2 TANC1 | 1.12e-05 | 588 | 204 | 14 | 38580884 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | SETX ZNF148 USP11 CUL9 CHUK UBA7 MDN1 AGL DYNC1H1 NCAPD3 OGT COPA UBR4 BEND3 ZFHX4 CHEK2 TRIB1 | 1.38e-05 | 857 | 204 | 17 | 25609649 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ZNF148 MYCBP2 KIF1B TBC1D9 MDN1 NCAPD3 MYBBP1A COPA PHF12 CARMIL1 RICTOR MED1 VIRMA MTAP BRD2 CTPS1 | 1.51e-05 | 774 | 204 | 16 | 15302935 |
| Pubmed | MYCBP2 USP11 L2HGDH MDN1 WDR75 AGL VPS13A PKN3 NCAPD3 OGT SPTLC1 APBB1 RICTOR LRPPRC | 1.56e-05 | 606 | 204 | 14 | 36538041 | |
| Pubmed | 1.63e-05 | 9 | 204 | 3 | 15900300 | ||
| Pubmed | Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins. | 1.78e-05 | 190 | 204 | 8 | 15161933 | |
| Pubmed | 1.79e-05 | 313 | 204 | 10 | 20800603 | ||
| Pubmed | MYCBP2 USP9X CHUK C4A KNL1 KLHL4 RMND5A TNPO2 ANKRD44 BRD2 EIF2A NEURL4 EPB41 | 1.80e-05 | 533 | 204 | 13 | 25544563 | |
| Pubmed | USP9X GART L2HGDH BIRC6 AGL DYNC1H1 MYBBP1A CAD COPA UBR4 LRPPRC CTPS1 EPB41 | 1.83e-05 | 534 | 204 | 13 | 35032548 | |
| Pubmed | USP9X KIF1B GART DST DYNC1H1 MYBBP1A CAD COPA CARMIL1 ANKRD26 RICTOR LRPPRC CTPS1 EIF2A EPB41 | 2.12e-05 | 708 | 204 | 15 | 39231216 | |
| Pubmed | 2.31e-05 | 197 | 204 | 8 | 31620119 | ||
| Pubmed | ZNF148 DST KIF14 PUS7 KNL1 POLH APBB1 MED1 ARID2 RACGAP1 TANC1 EPB41 | 2.53e-05 | 472 | 204 | 12 | 38943005 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | MYCBP2 USP11 BIRC6 BLVRA GUF1 TRMT10C DST MDN1 WDR75 VPS13A HINT2 MYBBP1A CAD COPA TUT7 UBR4 SPTLC1 APBB1 BEND3 LRPPRC ARID2 TANC1 NEURL4 | 2.58e-05 | 1496 | 204 | 23 | 32877691 |
| Pubmed | 2.76e-05 | 202 | 204 | 8 | 24639526 | ||
| Pubmed | 3.19e-05 | 102 | 204 | 6 | 11214970 | ||
| Pubmed | USP11 BLVRA SERPINB5 MDN1 KAT8 PUS7 MYBBP1A CAD OGT COPA UBR4 MED1 PIAS1 VIRMA MED15 CCNH BRD2 EIF2A | 3.33e-05 | 1014 | 204 | 18 | 32416067 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 22737222 | ||
| Pubmed | Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. | 3.42e-05 | 2 | 204 | 2 | 16565498 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 15998580 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 19062096 | ||
| Pubmed | Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. | 3.42e-05 | 2 | 204 | 2 | 19933335 | |
| Pubmed | Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4. | 3.42e-05 | 2 | 204 | 2 | 2459207 | |
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 3.42e-05 | 2 | 204 | 2 | 17645767 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 12207352 | ||
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 3.42e-05 | 2 | 204 | 2 | 27758680 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 22387014 | ||
| Pubmed | Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner. | 3.42e-05 | 2 | 204 | 2 | 23749435 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 23918728 | ||
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 3.42e-05 | 2 | 204 | 2 | 3037333 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 11726230 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 4216347 | ||
| Pubmed | Sequence determination of the thiolester site of the fourth component of human complement. | 3.42e-05 | 2 | 204 | 2 | 6950384 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 8660986 | ||
| Pubmed | Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain. | 3.42e-05 | 2 | 204 | 2 | 8428773 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 24638111 | ||
| Pubmed | Transcriptional repression of C4 complement by hepatitis C virus proteins. | 3.42e-05 | 2 | 204 | 2 | 21345967 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 2572548 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 2302180 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 22151770 | ||
| Pubmed | C4d-positive chronic rejection: a frequent entity with a poor outcome. | 3.42e-05 | 2 | 204 | 2 | 18091514 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 29080553 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 6589636 | ||
| Pubmed | C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production. | 3.42e-05 | 2 | 204 | 2 | 25339671 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 17728371 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 23313051 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 6149580 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 6149581 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 27409165 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 12115608 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 3542363 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 2387317 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 16908004 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 7365238 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 7391573 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 17971360 | ||
| Pubmed | Clinical features of patients with homozygous complement C4A or C4B deficiency. | 3.42e-05 | 2 | 204 | 2 | 29928053 | |
| Pubmed | Analysis of C4 and the C4 binding protein in the MRL/lpr mouse. | 3.42e-05 | 2 | 204 | 2 | 17971229 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 6881182 | ||
| Pubmed | Partial C4 deficiency in juvenile idiopathic arthritis patients. | 3.42e-05 | 2 | 204 | 2 | 17921792 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 21880985 | ||
| Pubmed | Amino acid sequence around the thiol and reactive acyl groups of human complement component C4. | 3.42e-05 | 2 | 204 | 2 | 6978711 | |
| Pubmed | A defect in COPI-mediated transport of STING causes immune dysregulation in COPA syndrome. | 3.42e-05 | 2 | 204 | 2 | 32725126 | |
| Pubmed | Mutations in COPA lead to abnormal trafficking of STING to the Golgi and interferon signaling. | 3.42e-05 | 2 | 204 | 2 | 32725128 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 35898513 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 28873507 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 10438935 | ||
| Interaction | UBXN6 interactions | SETX STING1 CHUK DST MDN1 KNL1 OGT COPA RICTOR ZNFX1 TRIM39 NLRP2 CHEK2 EIF2A TRIB1 | 1.06e-06 | 325 | 202 | 15 | int:UBXN6 |
| Interaction | LRRC31 interactions | RNF112 NCAPD3 MYBBP1A CAD COPA TUT7 RICTOR ZNFX1 FRYL MED1 LRRC31 NEURL4 | 1.13e-06 | 205 | 202 | 12 | int:LRRC31 |
| Interaction | KRT8 interactions | DCDC1 USP9X SIPA1L3 BIRC6 NAGS SCN4A KIF14 VCAM1 CAD OGT RMND5A UBR4 ANKRD26 RICTOR OVCH1 VIRMA CCDC71 | 2.39e-06 | 441 | 202 | 17 | int:KRT8 |
| Interaction | SIRT7 interactions | MYCBP2 USP11 USP9X GART CUL9 BIRC6 DST MDN1 WDR75 KIF14 DYNC1H1 MYBBP1A CAD COPA POLH TUT7 UBR4 NSD1 BEND3 FRYL VIRMA LRPPRC | 6.01e-06 | 744 | 202 | 22 | int:SIRT7 |
| Interaction | ITGB2 interactions | 7.49e-06 | 132 | 202 | 9 | int:ITGB2 | |
| Interaction | BRCA1 interactions | SETX ZNF148 USP11 USP9X KIF1B GART DST MDN1 AGO3 AGL DCLRE1A DYNC1H1 KNL1 CFAP47 NCAPD3 MYBBP1A CAD OGT COPA PHF12 POLH UBR4 ANKRD26 RICTOR PIAS1 CCNH ANKRD44 CHEK2 RACGAP1 CTPS1 | 7.54e-06 | 1249 | 202 | 30 | int:BRCA1 |
| Interaction | ENO1 interactions | USP11 KIF1B GART STING1 LRRC42 VPS13A HINT2 KIF14 DYNC1H1 VCAM1 PUS7 KLHL4 NCAPD3 CYSLTR2 OGT RMND5A RICTOR ZNFX1 VIRMA CHEK2 HTT | 8.14e-06 | 701 | 202 | 21 | int:ENO1 |
| Interaction | PHF21A interactions | MYCBP2 STING1 BIRC6 DST KIF14 PKN3 KNL1 OGT PHF12 POLH UBR4 BEND3 RLF ZFHX4 | 1.01e-05 | 343 | 202 | 14 | int:PHF21A |
| Interaction | MYCBP2 interactions | MYCBP2 USP11 SIPA1L3 TBC1D9 TRANK1 DST MDN1 KIF14 DYNC1H1 MYBBP1A CAD UBR4 VIRMA NEURL4 | 1.48e-05 | 355 | 202 | 14 | int:MYCBP2 |
| Interaction | SEC14L3 interactions | 1.94e-05 | 6 | 202 | 3 | int:SEC14L3 | |
| Interaction | SFN interactions | MYCBP2 SIPA1L3 KIF1B SERPINB5 DST KIF14 NRBP1 CARMIL1 ANKRD26 RICTOR FRYL PIAS1 VIRMA CCNH CCDC88C NEK8 RACGAP1 TANC1 PAN3 HTT | 2.26e-05 | 692 | 202 | 20 | int:SFN |
| Interaction | MICAL2 interactions | 2.45e-05 | 35 | 202 | 5 | int:MICAL2 | |
| Interaction | TOP3B interactions | MYCBP2 ANKRD37 SIPA1L3 KIF1B CUL9 ATG2A SRCAP BIRC6 TBC1D9 VOPP1 DST MDN1 KIF14 PREX1 DYNC1H1 PKN3 CAD PHF12 UBR4 KAT6A NSD1 FRYL CCDC88C BRD2 LRRC31 NEK8 RACGAP1 TANC1 EIF2A TRIB1 HTT HR | 2.63e-05 | 1470 | 202 | 32 | int:TOP3B |
| Interaction | YWHAG interactions | MYCBP2 SIPA1L3 KIF1B STING1 CDK14 PANK2 DST MDN1 CLK3 KIF14 DYNC1H1 NRBP1 CAD OGT CARMIL1 APBB1 ANKRD26 RICTOR FRYL PIAS1 VIRMA CCDC88C RACGAP1 TANC1 PAN3 CTPS1 EPB41 HTT | 5.29e-05 | 1248 | 202 | 28 | int:YWHAG |
| Interaction | TCP1 interactions | CTTNBP2 USP11 USP9X GART STING1 SCN4A KIF14 KLHL8 VCAM1 OGT RAPSN COPA RICTOR PIAS1 VIRMA CCDC71 HTT | 5.34e-05 | 561 | 202 | 17 | int:TCP1 |
| Interaction | YWHAQ interactions | MYCBP2 USP11 SIPA1L3 KIF1B CDK14 PANK2 DST CLK3 KIF14 BANK1 DYNC1H1 NRBP1 CAD ANKRD26 RICTOR FRYL MED1 VIRMA CCDC88C LRPPRC RACGAP1 TANC1 PAN3 CTPS1 EPB41 HTT | 5.58e-05 | 1118 | 202 | 26 | int:YWHAQ |
| GeneFamily | SEC14 family|PRELI domain containing | 8.19e-06 | 6 | 136 | 3 | 1063 | |
| GeneFamily | Ankyrin repeat domain containing | CTTNBP2 ANKRD37 ANKMY1 TRANK1 BANK1 ANKK1 ANKRD26 ANKRD23 ANKRD44 TANC1 | 1.49e-05 | 242 | 136 | 10 | 403 |
| GeneFamily | NLR family | 8.48e-04 | 25 | 136 | 3 | 666 | |
| GeneFamily | Pyrin domain containing|Pyrin and HIN domain family | 8.48e-04 | 25 | 136 | 3 | 994 | |
| GeneFamily | Zinc fingers MIZ-type | 1.15e-03 | 7 | 136 | 2 | 85 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 1.95e-03 | 9 | 136 | 2 | 1234 | |
| GeneFamily | BEN domain containing | 1.95e-03 | 9 | 136 | 2 | 422 | |
| GeneFamily | UPF1 like RNA helicases | 2.95e-03 | 11 | 136 | 2 | 1169 | |
| GeneFamily | WD repeat domain containing | 3.71e-03 | 262 | 136 | 7 | 362 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | SETX CTTNBP2 ZNF148 MYCBP2 USP9X TBC1D9 DMXL1 TRMT10C SCML1 KIF14 SLC27A3 KNL1 RUBCNL TUT7 RLF CCNH THBD ZNF654 | 3.67e-06 | 656 | 202 | 18 | M18979 |
| ToppCell | nucseq-Immune-Lymphocytic_B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | MYCBP2 SIPA1L3 EML6 CDK14 VOPP1 BANK1 RUBCNL ANKRD44 CCDC88C | 1.95e-07 | 184 | 205 | 9 | 911658e7bb499c1bbc8419eec8ff88729bc39a75 |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | MYCBP2 SIPA1L3 EML6 CDK14 VOPP1 BANK1 RUBCNL ANKRD44 CCDC88C | 1.95e-07 | 184 | 205 | 9 | 942b58ae7172bb5f97e55b032db9329d161854af |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 2.14e-07 | 186 | 205 | 9 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | MYCBP2 DMXL1 CXCR5 TRIM38 BANK1 CARMIL1 RUBCNL MKNK2 ANKRD44 | 3.05e-07 | 194 | 205 | 9 | ff661419b697aef51a53fdeac8d37d870d65f491 |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B-B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.02e-06 | 181 | 205 | 8 | 8d8cc4dae2c8bd5f4b1c159f2a52edc4c9449c86 | |
| ToppCell | COPD-Lymphoid-B_Plasma|Lymphoid / Disease state, Lineage and Cell class | 2.10e-06 | 182 | 205 | 8 | 19db653fe04c5e2957eea1f4893b1c1fca4ddcbd | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_B-Naive_B_cells|GI_large-bowel / Manually curated celltypes from each tissue | 2.37e-06 | 185 | 205 | 8 | 1c99373c123b5e0de40b47d9d885974a747b9839 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.37e-06 | 185 | 205 | 8 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | Control-Lymphoid-B_Plasma|Lymphoid / Disease state, Lineage and Cell class | 2.47e-06 | 186 | 205 | 8 | a08a50bff4e629588faa22440d57334b1df0e8df | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.57e-06 | 187 | 205 | 8 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_D3|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.01e-06 | 191 | 205 | 8 | d7920f4a602b50d0ef064eb47001e71939695ed2 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.25e-06 | 193 | 205 | 8 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 3.25e-06 | 193 | 205 | 8 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.51e-06 | 195 | 205 | 8 | 83c125223e7ca0f08a31414b3a16347912564765 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-06 | 195 | 205 | 8 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.78e-06 | 197 | 205 | 8 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | distal-3-Epithelial-Proximal_Ciliated|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.78e-06 | 197 | 205 | 8 | 15b4d1203943ce90a7083178d4a4284d9b323071 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_ciliated-Deuterosomal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.93e-06 | 198 | 205 | 8 | f31790442ef142f1c0c49bf3daf2d0efb193d2c9 | |
| ToppCell | distal-Epithelial-Ciliated-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.07e-06 | 199 | 205 | 8 | 2de1fe124737a6cca4b3805ab3056f9d9d7c16c7 | |
| ToppCell | distal-Epithelial-Ciliated-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.07e-06 | 199 | 205 | 8 | 6ce0df4a6f4d9353919e26ffab97c9ec89911da6 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.23e-06 | 200 | 205 | 8 | 55c148238d5c80c1faa3428a917ae8075be2c145 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.23e-06 | 200 | 205 | 8 | 52aef65f01b06cd98056f17977efe525aee6eb6f | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.23e-06 | 200 | 205 | 8 | 31d75c26055177d656df1fbb10b764cebd61e122 | |
| ToppCell | Biopsy_Other_PF-Epithelial-Ciliated|Biopsy_Other_PF / Sample group, Lineage and Cell type | 4.23e-06 | 200 | 205 | 8 | 721371698bce8890853fb6b6b01a2c20293b39e9 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.23e-06 | 200 | 205 | 8 | 85c98da55f7cd4ffdf9d309b56c8cc5d43f3c04c | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.23e-06 | 200 | 205 | 8 | e1dce91c6c531bb212002a14705e496d77ad3490 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.23e-06 | 200 | 205 | 8 | 12bc7d95c4166d12487081a76d210b7abe5991b0 | |
| ToppCell | Control-B_intermediate-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.26e-05 | 167 | 205 | 7 | 948504367ecf58144d9dd74d2ec531358fc4b309 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Secretory/RAS|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.41e-05 | 170 | 205 | 7 | b62f7184e78e9672ea88e361654f604f9df2dc5f | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Secretory/RAS-Secretory|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.41e-05 | 170 | 205 | 7 | 00fe77bca9c28762212c498f9c49e14cb1492cca | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-BM_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-05 | 171 | 205 | 7 | 6f49537f8d3cf18e65aa999fec32ed347ce2da3e | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-05 | 171 | 205 | 7 | ab97ae2b127a585f170f028f1c475cdd1b0cdea5 | |
| ToppCell | mild_COVID-19_(asymptomatic)-B_memory|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 1.58e-05 | 173 | 205 | 7 | 9082ad77b44f65b72094df6e502cce81b62fe81a | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-05 | 176 | 205 | 7 | 24b2e94ee5defcefb64a1f2447a2cc71b015b0fd | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.83e-05 | 177 | 205 | 7 | f360f7099570d248531897b96e0de282e58f59e9 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 2.19e-05 | 182 | 205 | 7 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-05 | 123 | 205 | 6 | a45d6907c041ad3f3218cd46dccfc25d4bd961cb | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.35e-05 | 184 | 205 | 7 | 081d045f3bc98a36f342de7d50f39c9a888dd7eb | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.35e-05 | 184 | 205 | 7 | 84c20730cd92b9aaa50077d7b625e37e7f9e91d2 | |
| ToppCell | P07-Epithelial-airway_epithelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.35e-05 | 184 | 205 | 7 | a5e7af3392e9d6ddad0397f1eeb6b91ed1107cc2 | |
| ToppCell | P07-Epithelial-airway_epithelial_cell-club_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.35e-05 | 184 | 205 | 7 | ab469b9e06212462cbe2e4db8775c6778db855e6 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.35e-05 | 184 | 205 | 7 | d31d4116d1d196633784863781fa45673607a421 | |
| ToppCell | Control-immature_Neutrophil-|Control / Disease condition and Cell class | 2.35e-05 | 184 | 205 | 7 | c4e8ba82a6aa76c46f05a71d5f1c7926555318cf | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.35e-05 | 184 | 205 | 7 | a8c6028d745aaa6ee7842259238694cb50ce0526 | |
| ToppCell | Control-Myeloid_G-immature_Neutrophil|Control / Disease group, lineage and cell class | 2.35e-05 | 184 | 205 | 7 | 45f873236f7e90fb78c8e291d3b5b92d121acec9 | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 2.35e-05 | 184 | 205 | 7 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | Control-immature_Neutrophil|Control / Disease condition and Cell class | 2.35e-05 | 184 | 205 | 7 | 2fdae5c6b3eb2232881d933a8c1061fda3623016 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.38e-05 | 124 | 205 | 6 | a7b7d8b14d1218194da8fcf69b4780b6e9469332 | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-05 | 185 | 205 | 7 | bb5a4cf93534b9bcd0923f314c389d571e91e7f8 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.52e-05 | 186 | 205 | 7 | 85787ff207f109ec7e3c0f729ba9bda739c2fdc9 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.52e-05 | 186 | 205 | 7 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid-Cd4_positive_Macrophages|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-05 | 188 | 205 | 7 | b2472a294b25fc2f0da7f18519fdcb9ca166c6f0 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.70e-05 | 188 | 205 | 7 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-05 | 188 | 205 | 7 | bf77e59b9001c7f7ca17f81073f935f281a25a1f | |
| ToppCell | COVID-19-lung-Ciliated|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.79e-05 | 189 | 205 | 7 | a2da5debd10f27b1280b40141ef0bfef007cc72c | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.79e-05 | 189 | 205 | 7 | dc440015949a768188c67661b6be63b1ead1a0f0 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.79e-05 | 189 | 205 | 7 | a3cd4c2da4feb9bdcd8957f3e344d095da1367b8 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.79e-05 | 189 | 205 | 7 | 93b1026bb1ba759e5704561c9a5de14a30c08894 | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.89e-05 | 190 | 205 | 7 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.99e-05 | 191 | 205 | 7 | 46c9d4d10c66c0fae1fa351924091b69ea2f38d4 | |
| ToppCell | Mild_COVID-19-Epithelial-Ciliated|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 2.99e-05 | 191 | 205 | 7 | 995e76bbf07674d95b8ef09e078cf6410af27a09 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.99e-05 | 191 | 205 | 7 | a37f20172b85566b9039254a89680e37fd503fd5 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-F_(Ciliated)|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.99e-05 | 191 | 205 | 7 | e314dd8f1a841cab847ae3703bedfe1bc623ac61 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B-Memory_B_cells|bone_marrow / Manually curated celltypes from each tissue | 2.99e-05 | 191 | 205 | 7 | 67479df0ca4c5a792fd604aded3f75609fec0888 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.99e-05 | 191 | 205 | 7 | 5a9a592875fbd0b1429b48db29a760fdc9c2c856 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.99e-05 | 191 | 205 | 7 | 2a8e6d560907e71e9f6e190ca0667da804e25641 | |
| ToppCell | Control-Lymphoid_B-B_intermediate|Control / Disease group, lineage and cell class | 2.99e-05 | 191 | 205 | 7 | 0082181dbc39c7c4fd3aa34c3ed61439548e844b | |
| ToppCell | 356C-Epithelial_cells-Epithelial-F_(Ciliated)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.99e-05 | 191 | 205 | 7 | 8a5a2188b13ef4bbfd626a42565566708a751c1b | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 2.99e-05 | 191 | 205 | 7 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.99e-05 | 191 | 205 | 7 | 2d36e08c5629cf73b6dd02cd173cafb52e8a3a7d | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.99e-05 | 191 | 205 | 7 | 4a29b7d5cd10e9077699d3aa76e3db6c4d5a0cf6 | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 3.19e-05 | 193 | 205 | 7 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.19e-05 | 193 | 205 | 7 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | Healthy_donor-B_intermediate|Healthy_donor / disease group, cell group and cell class (v2) | 3.19e-05 | 193 | 205 | 7 | e2be57bf3cbbbbff64853f06b9c11b136f73eea7 | |
| ToppCell | Frontal_cortex-Macroglia-OLIGODENDROCYTE-O2-Tnr-Oligodendrocyte.Tnf.Igsf8_(Ctps)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.21e-05 | 79 | 205 | 5 | 4c9c3051cb8a9c39c6df20e3fe37242db4b44280 | |
| ToppCell | Frontal_cortex-Macroglia-OLIGODENDROCYTE-O2-Tnr-Oligodendrocyte.Tnf.Igsf8_(Ctps)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.21e-05 | 79 | 205 | 5 | eddad041c0bc6952d9c68a36bdd78f6d661f0e58 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.30e-05 | 194 | 205 | 7 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | COVID-19_Mild-Lymphoid_B-B_intermediate|COVID-19_Mild / Disease group, lineage and cell class | 3.30e-05 | 194 | 205 | 7 | bf6f72a489c62cbf1a679552d8c5eaaaa0b99d33 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|COVID-19 / Condition, Lineage and Cell class | 3.30e-05 | 194 | 205 | 7 | 43be5fbd51dd58839cb03ca3ddd05a458e1ddb74 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-05 | 195 | 205 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Severe_COVID-19-Epithelial-Ciliated|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 3.52e-05 | 196 | 205 | 7 | 1cdef976a754c90d18b6149d367bd64e6e99b0a9 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.52e-05 | 196 | 205 | 7 | 69f5081e06d84ec1d9695762df801a9d0df1984b | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.52e-05 | 196 | 205 | 7 | 686a5a0ddb00929842c1c98445c59edfcc9a8a04 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.52e-05 | 196 | 205 | 7 | 67aefc480714e4b8c9ae53c036efdc07ec6f94af | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.52e-05 | 196 | 205 | 7 | ca56311edc6788e032e7635fa69b1e07035202b5 | |
| ToppCell | PSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.64e-05 | 197 | 205 | 7 | 6865f4831eb23794fb88a8649d48d497bbae3f44 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.64e-05 | 197 | 205 | 7 | 71fea4aa6ce96c7693fa94792d08770622873850 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-B_lymphocytic-B_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.64e-05 | 197 | 205 | 7 | 85b5d284e7799335a1829a5d2d56bb0845f5cec5 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.64e-05 | 197 | 205 | 7 | 0f489d26e4013d1b5a90559856ed2de32a0bb772 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.64e-05 | 197 | 205 | 7 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.64e-05 | 197 | 205 | 7 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.64e-05 | 197 | 205 | 7 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.64e-05 | 197 | 205 | 7 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.64e-05 | 197 | 205 | 7 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.64e-05 | 197 | 205 | 7 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Ciliated|LPS_only / Treatment groups by lineage, cell group, cell type | 3.75e-05 | 198 | 205 | 7 | 6d90b541fde357fbb40f8f7d4e8628a48b679718 | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.88e-05 | 199 | 205 | 7 | 15f7814b7074170eee7ccacaa670b1d128fc68bb | |
| ToppCell | distal-3-Epithelial-Ciliated|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.88e-05 | 199 | 205 | 7 | 7e5f29f4ec1fea92f2c0064eea151d2d474ef904 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.88e-05 | 199 | 205 | 7 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Mesenchymal-Cilia-bearing_cell|10w / Sample Type, Dataset, Time_group, and Cell type. | 3.88e-05 | 199 | 205 | 7 | 2d8ab4aee300c7c4baf662940ce855da2b6d2cae | |
| Disease | congenital dyserythropoietic anemia (is_implicated_in) | 4.53e-05 | 2 | 199 | 2 | DOID:1338 (is_implicated_in) | |
| Disease | hepatitis B virus infection, hepatocellular carcinoma | 4.53e-05 | 2 | 199 | 2 | EFO_0000182, EFO_0004197 | |
| Disease | primary autosomal recessive microcephaly (is_implicated_in) | 1.59e-04 | 16 | 199 | 3 | DOID:0070296 (is_implicated_in) | |
| Disease | iron biomarker measurement | 3.10e-04 | 48 | 199 | 4 | EFO_0004461 | |
| Disease | Autosomal Recessive Primary Microcephaly | 4.23e-04 | 22 | 199 | 3 | C3711387 | |
| Disease | hereditary sensory neuropathy (implicated_via_orthology) | 4.47e-04 | 5 | 199 | 2 | DOID:0050548 (implicated_via_orthology) | |
| Disease | frailty measurement | 4.84e-04 | 23 | 199 | 3 | EFO_0009885 | |
| Disease | gene methylation measurement | 6.67e-04 | 6 | 199 | 2 | EFO_0006959 | |
| Disease | unipolar depression, depressive symptom measurement | 7.01e-04 | 26 | 199 | 3 | EFO_0003761, EFO_0007006 | |
| Disease | lissencephaly (implicated_via_orthology) | 7.84e-04 | 27 | 199 | 3 | DOID:0050453 (implicated_via_orthology) | |
| Disease | reticulocyte measurement | USP9X EML6 ITGAD BIRC6 VPS13A ANTXR1 SEC14L4 PREX1 RMND5A TUT7 BEND3 RICTOR MTAP NEK8 CHEK2 TRIB1 EPB41 | 8.32e-04 | 1053 | 199 | 17 | EFO_0010700 |
| Disease | triglycerides to total lipids in IDL percentage | 8.76e-04 | 63 | 199 | 4 | EFO_0022329 | |
| Disease | Cerebral ventriculomegaly | 9.29e-04 | 7 | 199 | 2 | C1531647 | |
| Disease | Hydrocephalus Ex-Vacuo | 9.29e-04 | 7 | 199 | 2 | C0270720 | |
| Disease | Communicating Hydrocephalus | 9.29e-04 | 7 | 199 | 2 | C0009451 | |
| Disease | Fetal Cerebral Ventriculomegaly | 9.29e-04 | 7 | 199 | 2 | C2936718 | |
| Disease | Post-Traumatic Hydrocephalus | 9.29e-04 | 7 | 199 | 2 | C0477432 | |
| Disease | Obstructive Hydrocephalus | 9.29e-04 | 7 | 199 | 2 | C0549423 | |
| Disease | total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer | 1.23e-03 | 69 | 199 | 4 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992 | |
| Disease | Leigh syndrome | 1.23e-03 | 8 | 199 | 2 | cv:C0023264 | |
| Disease | xerostomia | 1.23e-03 | 8 | 199 | 2 | EFO_0009869 | |
| Disease | Congenital Hydrocephalus | 1.23e-03 | 8 | 199 | 2 | C0020256 | |
| Disease | pantothenate measurement | 1.23e-03 | 8 | 199 | 2 | EFO_0021034 | |
| Disease | female breast cancer (is_implicated_in) | 1.23e-03 | 8 | 199 | 2 | DOID:0050671 (is_implicated_in) | |
| Disease | Aqueductal Stenosis | 1.23e-03 | 8 | 199 | 2 | C2936786 | |
| Disease | Lupus Erythematosus, Systemic | 1.37e-03 | 71 | 199 | 4 | C0024141 | |
| Disease | cholesteryl esters to total lipids in very small VLDL percentage | 1.37e-03 | 71 | 199 | 4 | EFO_0022259 | |
| Disease | Complement deficiency disease | 1.42e-03 | 33 | 199 | 3 | C0272242 | |
| Disease | Hydrocephalus | 1.58e-03 | 9 | 199 | 2 | C0020255 | |
| Disease | Primary ciliary dyskinesia | 1.83e-03 | 36 | 199 | 3 | cv:C0008780 | |
| Disease | cholesteryl esters to total lipids in very large HDL percentage | 1.83e-03 | 36 | 199 | 3 | EFO_0022257 | |
| Disease | Anemia, Sickle Cell | 1.97e-03 | 10 | 199 | 2 | C0002895 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.97e-03 | 10 | 199 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.97e-03 | 10 | 199 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | neuroblastoma (is_implicated_in) | 1.97e-03 | 10 | 199 | 2 | DOID:769 (is_implicated_in) | |
| Disease | cholate measurement | 1.97e-03 | 10 | 199 | 2 | EFO_0021509 | |
| Disease | free cholesterol to total lipids in large VLDL percentage | 1.98e-03 | 37 | 199 | 3 | EFO_0022281 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 2.44e-03 | 200 | 199 | 6 | EFO_0004611, EFO_0020945 | |
| Disease | free cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 2.77e-03 | 86 | 199 | 4 | EFO_0008595, EFO_0020945 | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 2.86e-03 | 12 | 199 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Charcot-Marie-Tooth Disease | 2.86e-03 | 12 | 199 | 2 | C0007959 | |
| Disease | Autoimmune Diseases | 2.86e-03 | 42 | 199 | 3 | C0004364 | |
| Disease | sphingomyelin measurement | 2.91e-03 | 278 | 199 | 7 | EFO_0010118 | |
| Disease | cognitive function measurement, self reported educational attainment | 2.95e-03 | 355 | 199 | 8 | EFO_0004784, EFO_0008354 | |
| Disease | systemic lupus erythematosus (implicated_via_orthology) | 3.06e-03 | 43 | 199 | 3 | DOID:9074 (implicated_via_orthology) | |
| Disease | concentration of large LDL particles measurement | 3.27e-03 | 44 | 199 | 3 | EFO_0022160 | |
| Disease | X-11444 measurement | 3.36e-03 | 13 | 199 | 2 | EFO_0021237 | |
| Disease | hematologic cancer (implicated_via_orthology) | 3.36e-03 | 13 | 199 | 2 | DOID:2531 (implicated_via_orthology) | |
| Disease | amyotrophic lateral sclerosis (biomarker_via_orthology) | 3.36e-03 | 13 | 199 | 2 | DOID:332 (biomarker_via_orthology) | |
| Disease | mean corpuscular hemoglobin concentration | ALDH8A1 DMXL1 VPS13A ANTXR1 PREX1 RAPSN RMND5A CYP26B1 CARMIL1 BEND3 ABCA6 CHEK2 PAN3 TRIB1 ZNF654 EPB41 | 3.50e-03 | 1105 | 199 | 16 | EFO_0004528 |
| Disease | Kartagener syndrome (implicated_via_orthology) | 3.90e-03 | 14 | 199 | 2 | DOID:0050144 (implicated_via_orthology) | |
| Disease | level of Phosphatidylethanolamine (18:2_0:0) in blood serum | 3.90e-03 | 14 | 199 | 2 | OBA_2045143 | |
| Disease | sulfate measurement | 3.90e-03 | 14 | 199 | 2 | EFO_0007864 | |
| Disease | total lipids in small LDL | 3.94e-03 | 47 | 199 | 3 | EFO_0022168 | |
| Disease | free cholesterol in small VLDL measurement | 3.94e-03 | 47 | 199 | 3 | EFO_0022272 | |
| Disease | free cholesterol in medium VLDL measurement | 3.94e-03 | 47 | 199 | 3 | EFO_0022269 | |
| Disease | Primary Ciliary Dyskinesia | 3.94e-03 | 47 | 199 | 3 | C4551720 | |
| Disease | glaucoma | 3.99e-03 | 154 | 199 | 5 | MONDO_0005041 | |
| Disease | cholesterol in small LDL measurement | 4.43e-03 | 49 | 199 | 3 | EFO_0022227 | |
| Disease | phosphatidylcholine 36:3 measurement | 4.49e-03 | 15 | 199 | 2 | EFO_0010381 | |
| Disease | hepcidin:transferrin saturation ratio | 4.49e-03 | 15 | 199 | 2 | EFO_0007902 | |
| Disease | polyunsaturated fatty acids to total fatty acids percentage | 4.69e-03 | 50 | 199 | 3 | EFO_0022303 | |
| Disease | total cholesterol measurement, diastolic blood pressure, triglyceride measurement, systolic blood pressure, hematocrit, ventricular rate measurement, glucose measurement, body mass index, high density lipoprotein cholesterol measurement | 4.96e-03 | 51 | 199 | 3 | EFO_0004340, EFO_0004348, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928 | |
| Disease | cholesterol to total lipids in small HDL percentage | 4.96e-03 | 51 | 199 | 3 | EFO_0022240 | |
| Disease | cholesterol to total lipids in small VLDL percentage | 4.96e-03 | 51 | 199 | 3 | EFO_0022242 | |
| Disease | reticulocyte count | USP9X EML6 ALDH8A1 ITGAD BIRC6 VPS13A ANTXR1 C4B SEC14L4 RMND5A BEND3 MTAP NEK8 TRIB1 EPB41 | 5.02e-03 | 1045 | 199 | 15 | EFO_0007986 |
| Disease | 2-hydroxyglutarate measurement | 5.10e-03 | 16 | 199 | 2 | EFO_0021506 | |
| Disease | total lipids in medium LDL | 5.24e-03 | 52 | 199 | 3 | EFO_0022180 | |
| Disease | squamous cell lung carcinoma | 5.33e-03 | 165 | 199 | 5 | EFO_0000708 | |
| Disease | sleep duration, triglyceride measurement | 5.46e-03 | 104 | 199 | 4 | EFO_0004530, EFO_0005271 | |
| Disease | lung carcinoma | 5.66e-03 | 482 | 199 | 9 | EFO_0001071 | |
| Disease | eicosapentaenoate EPA; 20:5n3 measurement | 5.76e-03 | 17 | 199 | 2 | EFO_0021049 | |
| Disease | Charcot-Marie-Tooth disease type 2 | 5.76e-03 | 17 | 199 | 2 | cv:C0270914 | |
| Disease | level of Phosphatidylcholine (14:0_18:2) in blood serum | 5.76e-03 | 17 | 199 | 2 | OBA_2045063 | |
| Disease | hepcidin:ferritin ratio | 6.13e-03 | 55 | 199 | 3 | EFO_0007901 | |
| Disease | autoimmune disease | 6.49e-03 | 173 | 199 | 5 | EFO_0005140 | |
| Disease | Cholestasis | 6.65e-03 | 110 | 199 | 4 | C0008370 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LALKLLKRCNILHAD | 801 | Q13523 | |
| LLHCAAKFGLKNLAI | 346 | Q8NDB2 | |
| AKFGLKNLAIHLLQC | 351 | Q8NDB2 | |
| CKSKDIVLVAHSALG | 206 | P17516 | |
| LKLIALCHSSGIKQD | 636 | Q7L0X2 | |
| KGQDLLKRVCEHLNL | 231 | P11171 | |
| QLSAPHCKKLSLELG | 241 | Q9H2A2 | |
| HLGDTLIIKCDTKQQ | 281 | Q86WK6 | |
| AVLKQKLERCHSAEL | 271 | P51946 | |
| ACLKGHSQLVNKLLV | 151 | Q86SG2 | |
| QALQGIIHSILKKSC | 206 | Q9H6X2 | |
| AEVLLKERKHAQCLL | 4171 | Q9NR09 | |
| VLGTFLCKTVIALHK | 116 | P32302 | |
| LKDAKSCGLHQLLRG | 91 | P0C0L5 | |
| AHLAALKGNTAILKV | 696 | Q8NFD2 | |
| VSNLCSLGAKDLLHA | 611 | O95267 | |
| LRCIGSIQHLKNKLG | 1491 | Q8N139 | |
| LKSCLSADIQSKGHL | 201 | A8MVX0 | |
| LQDKHCSKDALLAGL | 1686 | Q68CP9 | |
| CLDHARGKSQVALKI | 321 | P49761 | |
| CLVNGLSLDHSKLVD | 511 | O00213 | |
| KHSLNNEKIILRGCI | 221 | Q8TF62 | |
| VDIHTLIKAGKKCLA | 261 | O95388 | |
| EASLLKGLKHANIVL | 181 | O94921 | |
| LSNLCLKINVKLGGI | 561 | Q9H9G7 | |
| AALSCERLLELKKNH | 731 | Q9UPS8 | |
| AGSKCLHLDTKNQIL | 1416 | Q9UPS8 | |
| DCLIKITDFGHSKIL | 361 | O96017 | |
| LNTDEIHLIGKCLKF | 36 | Q6UXS9 | |
| IHLIGKCLKFVVSNA | 41 | Q6UXS9 | |
| RAKAILSHLVKCIAG | 1341 | Q9Y485 | |
| CHFQVLSNLDKGTLK | 376 | Q8IWY9 | |
| LIGLAQLNCSELKLK | 1696 | Q2TAZ0 | |
| APLHKAAKVGSLECL | 66 | Q7Z713 | |
| STCGLLETQIKKLHN | 496 | Q9UFE4 | |
| TIDGLKATKNFLHCL | 351 | P24386 | |
| FCGNKIVENKILLHL | 341 | Q6ZP01 | |
| VLIETAKKLGLRCHS | 151 | Q13126 | |
| SEHDLLLNGCLKSLA | 466 | Q96L73 | |
| KDILKASLAHVAGCE | 581 | Q9H714 | |
| AEEVGNKLSQLKLHC | 316 | Q13702 | |
| HSIGKAICERLKDSL | 576 | Q8N442 | |
| SGHCKISLKLVDIND | 331 | Q9Y5H9 | |
| CGFAAKRKLESLHLQ | 291 | Q5T5X7 | |
| LQTAIKSNIGHLCKL | 446 | M0R2J8 | |
| EKAIEIIISALKGCH | 1511 | Q15058 | |
| IIISALKGCHSDINL | 1516 | Q15058 | |
| VHAQCLELKAKGLSL | 2886 | Q9NU22 | |
| HCKNASLLLGEKTII | 161 | Q7Z353 | |
| LGHLLLVAKQTAKAE | 111 | Q9BX68 | |
| CQLARHVLLLAGKSL | 101 | Q6UB28 | |
| ESLKAKLCVQGAALL | 106 | Q9H9P8 | |
| KSHGLIDEQILCQLK | 1611 | Q03001 | |
| GHLSKLLGCKQKIID | 606 | O15111 | |
| CTKHRGVLLQALNDK | 1771 | O60333 | |
| QNLCLLAKLFLDHKT | 261 | Q9H7Z6 | |
| CLGKHLAKLFLKVLA | 441 | Q9NR63 | |
| KLHANILVLCKDTLE | 241 | Q6ZUT3 | |
| CRGKLLVHSLNLLAK | 606 | A9Z1Z3 | |
| NLKHGLCALDPNKIS | 711 | Q8NDZ0 | |
| KLDNHCELLSRLKGN | 1316 | Q9P219 | |
| TRGLQKVLAKCLDNH | 1056 | Q5VYM1 | |
| LLASTAVKLCLGHER | 761 | O43593 | |
| LKVGSKLISCHKLVL | 71 | Q9P2G9 | |
| HISCAAKDLISKLLV | 336 | Q9HBH9 | |
| KALSGNAVLILLIHC | 41 | Q6IEZ7 | |
| KKVHQLGCEAVTLLL | 1146 | O94915 | |
| LHSCGLSQKSVKILD | 261 | Q6UY01 | |
| NGTVHLICKLDDKDL | 701 | Q96RN5 | |
| GIVHLCLRKADQKLV | 16 | Q86SG6 | |
| ERLNLHGKIGCLLSI | 106 | Q8N8Q9 | |
| AHLTKKLLDLVQQSC | 16 | P55769 | |
| TKGQLDCVITLHKDQ | 1401 | Q8NG31 | |
| AGCNQHILDKFILKV | 31 | Q969G2 | |
| LHCALLANKTDLAKA | 411 | P42704 | |
| LHLKDNCLSDAGVRK | 206 | Q9Y546 | |
| LAKSCKVLVDALRHN | 196 | Q8N159 | |
| SLLCLDLGLNHIGVK | 926 | Q9NX02 | |
| KGHEKCALLILDKIQ | 916 | Q8N8A2 | |
| KLGHLNNFTKLLCDI | 56 | Q6R327 | |
| QLHCAGLLEDKNKLI | 161 | Q96MC2 | |
| LKEKQLCDVLLIAGH | 176 | Q9C0H6 | |
| LELLNVLFRTCKHEK | 1086 | Q9BQG0 | |
| CKHEKLTLDLTVLLG | 1096 | Q9BQG0 | |
| LKLEDKLNRHLSCDL | 466 | Q9UHY1 | |
| KALSGNAVLILLIHC | 41 | Q8NH02 | |
| KTLGLGIHCETLKLL | 701 | Q13349 | |
| KDLTLCGRKGNLHFI | 271 | Q9BZ23 | |
| DLSHIISCLNKLDAG | 831 | Q58A45 | |
| QNLCLLAKLFLDHKT | 591 | Q92794 | |
| CSAVHLLLKKVLFAL | 76 | Q15884 | |
| CLGAKHKAQSLQLSL | 191 | Q8IV32 | |
| KKTLQCLEGIHLSQS | 1971 | P42858 | |
| AALLCLLKAIGSREH | 2246 | Q4G0P3 | |
| LAEANCLKGALIKTQ | 256 | Q9UG22 | |
| AALSILLNKAVLHGC | 1401 | Q8WZ74 | |
| LAKHAIVICNRKLDA | 506 | P53621 | |
| LRNIKLEHLKGLKCS | 106 | O95999 | |
| SIKEECATLHNIIKG | 61 | Q4G0S7 | |
| HKKDCGDLVAIVTQL | 916 | Q9P2S6 | |
| TLLCNGKFHKHLQEI | 916 | Q86UW7 | |
| LAAEKKRILHCLGLA | 271 | P53004 | |
| KRILHCLGLAEEIQK | 276 | P53004 | |
| LKNKLLSGNKLCGIH | 136 | Q86TE4 | |
| NCILLTKDEAAAHLK | 711 | Q8NA54 | |
| AKELKNIHVCLGGLF | 4501 | Q14204 | |
| KVLDKHSAQLLLGCE | 1086 | Q8IWT3 | |
| LKALLLGLACNHNLK | 441 | Q5VZK9 | |
| LKCLSLLKGQHQRGV | 761 | Q6ZMW3 | |
| CSEITGNLLKNKLHV | 751 | Q6PJP8 | |
| KLAKCLVNSAGCHLV | 121 | P56749 | |
| NKGLLHSFDLLKAVC | 66 | Q9BY44 | |
| CKSVVSLDGDKLVHI | 81 | O15540 | |
| IGHLLCKDELLKASL | 311 | Q7Z3D6 | |
| NKKHLILAFCAGVLL | 36 | Q8NEQ5 | |
| KVKCGLDLNQHELSA | 1836 | Q9C0D2 | |
| IQKSELALCLGLKIN | 261 | O76038 | |
| LLQECAHQTTKLGRK | 131 | O76054 | |
| ILHECDLQTERLGKK | 131 | Q9UDX4 | |
| LLHECELQTQKLGRK | 131 | Q9UDX3 | |
| CTLHDTVLNKILLKN | 1881 | Q6ZTR5 | |
| TNEALHKGCSLKVLA | 576 | Q66K64 | |
| LLCEHSKLSKLIILG | 606 | Q8NG08 | |
| DALLFHEKCGTLIKL | 316 | Q96JN8 | |
| LKDAKSCGLHQLLRG | 91 | P0C0L4 | |
| QHLVSCLETLQKALK | 56 | Q15648 | |
| KAIAERHGNLCLDKI | 521 | O15294 | |
| LCEVITSKDLQKHGN | 566 | Q2NL67 | |
| ACVVLGLQFLHEKKI | 666 | Q6P5Z2 | |
| LILLAKLCFQHKLGI | 171 | Q96EX2 | |
| HSCVLILGNKKLRQA | 276 | Q9NYV8 | |
| KLRAICLDHAKLGES | 1056 | Q93008 | |
| HGAQKAALVLLSACL | 16 | Q86WV6 | |
| LKHLGVKLGTAVKLC | 301 | Q9UN30 | |
| LKSHILELEEKCQGS | 226 | O00635 | |
| HKALLGLVKEINRCE | 286 | Q9HCM9 | |
| ALLALLCHLRKKQGA | 531 | P07204 | |
| DTGKALVCQAKLHID | 476 | P19320 | |
| KLVCGHIISRDALNK | 351 | Q9H871 | |
| GDKIHCLDILFALTK | 1671 | P35499 | |
| CKVKTIHLLTSLDEG | 146 | Q8WV92 | |
| AHCLDSLSEKQLKNI | 86 | Q7RTY7 | |
| VVALQCSILKHLSAK | 436 | Q96QT6 | |
| EDGKNQLLLALLKCT | 1301 | Q8TCU6 | |
| LKITAQRLAHLNKCL | 306 | Q96PZ0 | |
| ILKSCGLHVTSIKID | 26 | P17812 | |
| LLKLDEQGLCRKHKV | 611 | O60292 | |
| DVKLEDHLLAGSCLK | 676 | Q7Z333 | |
| HLDKKGQCALVHSAL | 996 | Q9C0D5 | |
| KGVALSNVIHKVCLE | 311 | P36952 | |
| ELQLKLARKCLHACG | 496 | O75592 | |
| ISHNKVLAKLACGLN | 216 | Q9Y253 | |
| ELLTKALHLLKAGCS | 36 | O75925 | |
| IQTISLLAHLACEKG | 651 | Q6ZRS2 | |
| HAICSLLKDFLRNLK | 416 | Q9H0H5 | |
| LKEKCGQIHKALQGI | 366 | O15269 | |
| ATVQLCLAVLAHKGL | 191 | Q9NP94 | |
| LSEQLKHCNGILKEL | 346 | P25440 | |
| RCTGDNEKVKAHILL | 106 | P56748 | |
| TLGKLCLQHEDLAKK | 926 | P42695 | |
| VGLCKDRLHKALVIT | 276 | Q9NS75 | |
| VLICNGKLKTLKLGH | 851 | Q7RTR0 | |
| ELLAKALHLLKSSCA | 36 | Q9Y6X2 | |
| NLITDTHLGKIICKE | 236 | Q9P2J8 | |
| LLLGLLLECTEAKKH | 11 | Q96AW1 | |
| CGKLFSNVLILKSHQ | 1906 | Q86UP3 | |
| QHLGKICDGLRKLLD | 166 | Q6P589 | |
| NACGKLLLNIKHDET | 171 | Q06732 | |
| HSKDQLNITLSKCGL | 1836 | Q96RL7 | |
| CHQSAIVLGDLKLRK | 196 | Q96RU8 | |
| KDAILARHGVALLCK | 501 | Q9ULX5 | |
| KALTDCGELALKQLH | 1866 | Q13129 | |
| LLKAIPDLDCASKAH | 941 | Q9C0H9 | |
| LQQAACLALKHLKGI | 871 | Q96MK2 | |
| CLALKHLKGIESIDQ | 876 | Q96MK2 | |
| AAKLEEQLKVGTLCH | 126 | P41226 | |
| KAARISHLKILQCQG | 296 | Q5K4L6 | |
| ILIKTFIVGCKLHAL | 91 | Q8IWA0 | |
| KEGCLQSELIQFHLK | 251 | Q5TF21 | |
| GKESLSKNLLLVALC | 86 | Q5U3C3 | |
| ALLGDLTKACFIHVK | 686 | O14787 | |
| CEKALQLLGDKSLHP | 306 | Q969T3 | |
| SAACHGDLTEKLKLL | 916 | Q6ZT07 | |
| LLHLEGKSCLLHARK | 541 | Q3MJ13 | |
| LEAHLAQKKCQTLFG | 1106 | Q8IZM8 | |
| CRKLFLQHEGLKQLI | 396 | Q8IYM2 | |
| IDICLKLLDKSLHFQ | 191 | O43548 | |
| CGKAFSLLTLLNRHK | 226 | O75290 | |
| VGTKLKIAQLCNKHD | 496 | P22102 | |
| ICLGHQLLALAIGAK | 251 | P27708 | |
| HVLGILKNSKFLKVC | 206 | Q9P2E3 | |
| ACGKLLLNIKHDETH | 171 | Q06730 | |
| LNSLLKHCLLKEVFQ | 1171 | Q8N9V7 | |
| KCLETLKGVLDVAHT | 266 | Q5JTN6 | |
| QGLKSLVGVLIHCLK | 221 | Q01118 | |
| QVLKKNELLHLGGRC | 751 | Q6PGP7 | |
| AKKLRLCHITSGEAL | 211 | Q8TCF1 | |
| HDKKLNRCAIKGGLL | 281 | Q9UQR1 | |
| KLALNKHLLGRLCQI | 2121 | O15050 | |
| AQGGAHLKQCDLLKL | 46 | O14905 | |
| CGKAFIQSSKLLLHQ | 436 | O75123 | |
| LQCKHLIKEGKLVEA | 141 | O75127 | |
| ACLTTKHLTALGKLE | 416 | Q5VYS8 | |
| CGKHVERALLVELNK | 911 | Q5VYS8 | |
| CGKSFRLKINLIIHQ | 551 | Q9ULD5 | |
| ACAVSQKHLILLIKG | 121 | Q5T4S7 | |
| QKHLILLIKGLCTGC | 126 | Q5T4S7 | |
| SHKDQALLSKAVQCL | 2541 | Q5T4S7 | |
| KACKLAILHLINGTI | 1236 | Q69YN4 | |
| FHRLCQLLKDLASKG | 2546 | Q6ZQQ6 | |
| KDIALLEHGCKALEV | 6 | A0A1B0GUJ8 | |
| CNLKIDGALHRELVK | 246 | Q7L0Y3 | |
| KISDLCVALSKHTGI | 521 | P51784 | |
| AHSLKCQKLTLADLI | 96 | A6NCI4 | |
| CLLHKVCDTGKALVA | 86 | Q9Y6Q6 | |
| DLKKAGQESQHCFLL | 66 | Q5GH70 | |
| ARCAISKLHQELGAK | 701 | P35573 | |
| HKLLVLEGQAATLKC | 296 | Q9ULH4 | |
| CIKLIKLDLHGNQIK | 71 | A6PVS8 | |
| SKLHASSVKGLCLAL | 736 | Q86W25 |